Aptevo Therapeutics aptevotherapeutics.com


Aptevo Therapeutics (Nasdaq: APVO) is a biotech company primarily focused on bringing oncology and hematology therapeutics to market. We leverage the ADAPTIR platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients.

Aptevo Therapeutics (Nasdaq: APVO) is a biotech company primarily focused on bringing oncology and hematology therapeutics to market. We leverage the ADAPTIR platform technology, a unique approach to cancer immunotherapy, to improve outcomes for canc...Show all

Company (Alive / Active)

Phone: 206-838-0500

Fax:

2401 4th Avenue
Suite 1050
Seattle, 98121
Washington, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Aptevo Therapeutics $0M Dec 30, 2020

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Aptevo Therapeutics Jobs

jobs by Indeed job
						search
There is no Investors data available for this company. Please select another tab.
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Cd123 binding proteins and related compositions and methods Mar 22, 2018 Jun 09, 2020 Patent
Cd37 immunotherapeutics and uses thereof Jul 25, 2006 Jun 04, 2019 Patent
Oncofetal antigen binding proteins and related compositions and methods Jul 20, 2018 Mar 26, 2019 Patent
Cd3 binding polypeptides Apr 18, 2013 Feb 12, 2019 Patent
B-cell reduction using cd37-specific and cd20-specific binding molecules Mar 15, 2013 Dec 04, 2018 Patent
See all 21 patents